Willis Towers Watson Public Limited Company

The filings show a business whose headline profit numbers improved sharply in 2025 and early 2026, but whose growth quality needs a closer read. Full-year 2025 operating income reached $2.23 billion against $627 million in 2024, and net income moved from a $98 million loss to $1.6 billion, which largely explains the strong year-over-year profit comparison. Revenue, by contrast, fell 2.3% to $9.52 billion. Health, Wealth & Career supplied 55% of 2025 revenue, while Risk & Broking supplied 45%. Corporate Risk & Broking places more than $34 billion of premiums into insurance markets each year, so its commission revenue moves with premium rates, which makes management's note of a softening market directly relevant. Currency exposure is also material: U.S. dollars represented 48% of Q1 2026 revenue, while pounds sterling represented 20% of expenses against 13% of revenue. On the forensic scores, the Beneish M-Score of -2.457 is below -1.78 and is not in the elevated manipulation-risk zone, though this is a screening result rather than proof that the figures are accurate. The Altman Z-Score of 1.50 falls in the grey zone, and because the label states the model is not designed for banks or financial firms, it should be interpreted cautiously. The Piotroski F-Score is 6 of 8 computable signals, meaning six of the eight applicable checks on profitability, leverage and efficiency were positive. Operating cash flow of $1.77 billion exceeded net income of $1.6 billion in 2025, a ratio of 1.11, which supports earnings quality on this measure. Readers may want to look at the Individual Marketplace and Benefits Delivery & Outsourcing sections of the 10-K, and the tariff and currency discussion in the 10-Q, to see how these pressures are described in management's own words.

Catalyst.Per the Q1 2026 10-Q MD&A, revenue rose to $2,412 million from $2,223 million, an 8% as-reported increase, but organic growth was 3%. Currency translation added $100 million, mainly from the Euro and Pound Sterling. Net income attributable to WTW reached $297 million versus $235 million, and diluted earnings per share were $3.10 versus $2.33. Management states that at the time of filing it is seeing a softening market, which puts downward pressure on commission revenue. For full-year 2025, revenue was $9.52 billion, down 2.3% from $9.74 billion, while operating income rose to $2.23 billion from $627 million in 2024.

Hidden risk.The MD&A describes a softening pricing market, and the risk factors say growth in Medicare exchange populations 'may be more episodic in nature.' Q1 2026 transaction and integration expenses of $41 million appeared, versus none in the prior-year quarter. At year-end 2025, liabilities were $21.48 billion against equity of $7.98 billion, and long-term debt rose to $5.76 billion from $5.31 billion. Net income also swung from a $98 million loss in 2024 to $1.6 billion in 2025, so single-year comparisons can mislead. The Altman Z-Score sits in the grey zone, and its label notes the model is not designed for financial firms, so readers may want to treat that reading with caution.